Hims & Hers CEO and CFO sell shares amid sharp earnings miss

The chief executive of Hims & Hers Health (NYSE:HIMS) sold 436,000 shares of company stock shortly before the company reported its Q1 2026 earnings on May 11, which missed expectations by a wide margin. The earnings release showed an earnings‑per‑share figure that fell dramatically, prompting market concern.

Separately, chief financial officer Oluyemi Okupe sold 7,950 shares on May 18 at an average price of $23.64, a transaction worth $187,938. After the sale, the CFO retained about 262,954 shares valued at roughly $6.2 million, representing a 2.93% reduction in his holdings. Both insider sales were disclosed in SEC filings.